Certolizumab Pegol
A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
Year introduced: 2016 (2003)
PubMed search builder options
Subheadings:
Tree Number(s): D05.750.741.125, D12.644.541.500.650.250, D12.776.124.486.485.114.224.060.500, D12.776.124.486.485.680.650.250, D12.776.124.790.651.114.224.060.500, D12.776.124.790.651.680.650.250, D12.776.377.715.548.114.224.200.500, D12.776.377.715.548.680.650.250
MeSH Unique ID: D000068582
Registry Number: UMD07X179E
Entry Terms:
See Also:
Pharmacologic Action: